Stay updated on Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding detailed descriptions of a clinical trial for nasopharyngeal cancer, including its objectives, methodology, and eligibility criteria. The revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    56%
    Check dated 2025-04-16T14:10:58.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and changed the date from March 25, 2025, to February 14, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T08:48:19.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:04:24.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:55:17.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page has updated key dates and removed references to previous dates, along with the deletion of the CCTU name. Additionally, the Chinese University of Hong Kong and Edwin P Hui have been added.
    Difference
    1%
    Check dated 2025-02-17T15:27:58.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:54:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.